David Penson, M.D.
Vanderbilt University
2525 West End Avenue
Nashville,
TN
USA
37203
Papers:
2F-2
COMPARATIVE SURVIVAL BENEFITS FROM INTERMITTENT VERSUS CONTINUOUS ANDROGEN DEPRIVATION THERAPY IN ADVANCED PROSTATE CANCER PATIENTS: A POPULATION-BASED STUDY
PATIENT EXPECTATIONS FROM TREATMENT OF INCURABLE METASTATIC PROSTATE CANCER